These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 203393
1. Mitomycin C in advanced adenocarcinoma and large cell carcinoma of the lung. Samson MK, Comis RL, Baker LH, Ginsberg S, Fraile RJ, Crooke ST. Cancer Treat Rep; 1978 Jan; 62(1):163-5. PubMed ID: 203393 [No Abstract] [Full Text] [Related]
2. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung. Fraile RJ, Samson MK, Baker LH, Talley RW. Cancer Treat Rep; 1979 Jan; 63(11-12):1983-7. PubMed ID: 230896 [Abstract] [Full Text] [Related]
3. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung. Eagan RT, Frytak S, Creagan ET, Ingle JN, Kvols LK, Coles DT. Cancer Treat Rep; 1979 Jan; 63(9-10):1589-91. PubMed ID: 227597 [No Abstract] [Full Text] [Related]
4. [Effect of adriamycin, mitomycin-C, and tegafur (AMF) chemotherapy on advanced lung cancer]. Nabeshima K, Iwahashi N, Fujii J, Tamura S, Hada T, Higashino K. Gan To Kagaku Ryoho; 1985 Jul; 12(7):1487-90. PubMed ID: 2990352 [Abstract] [Full Text] [Related]
5. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer]. Homma T, Yoneda S, Fukuda Y, Nakata M, Noguchi Y, Yoshida S. Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045 [Abstract] [Full Text] [Related]
6. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma. Salvati F, Cruciani AR, De Marinis A, Nunziati F, Portalone L. Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790 [Abstract] [Full Text] [Related]
7. [Mitomycin C, adriamycin and vinblastine after induction with cisplatin and VP-16 in the treatment of non-small cell lung carcinoma]. De Marinis A, Mugnaini L, Antilli A, Mollica C, Mecarocci D, Conte S, Salvati F. G Ital Chemioter; 1985 Mar; 32(1):73-5. PubMed ID: 3007255 [No Abstract] [Full Text] [Related]
8. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung]. Saito H, Nomura F, Kawatsu H, Sakai S, Kobayashi T, Shimokata K. Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062 [Abstract] [Full Text] [Related]
17. Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lung. Saijo N, Shimizu E, Eguchi K, Shinkai T, Tominaga K, Shibuya M, Shimabukuro Z, Niitani H, Hoshi A. Cancer Treat Rep; 1983 Apr; 67(4):385-7. PubMed ID: 6189601 [Abstract] [Full Text] [Related]
18. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study. Dombernowsky P, Sörenson S, Aisner J, Hansen HH. Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119 [No Abstract] [Full Text] [Related]